Back to Authors

Wieruszewski, Patrick

A5146721296 | I4210125099

Mayo Clinic in Arizona

Citations 5

878: THROMBOEMBOLIC EVENTS IN THE ANGIOTENSIN II FOR THE TREATMENT OF HIGH-OUTPUT SHOCK PHASE 3 TRIAL

Critical Care Medicine | March 24, 2026 | Volume: 54 | Issue: 3S | Pages: No page available

10.1097/01.ccm.0001185508.53311.c6

1637: CLINICAL OUTCOMES OF ROUTINE ANTITHROMBIN SUPPLEMENTATION DURING EXTRACORPOREAL MEMBRANE OXYGENATION

Critical Care Medicine | March 24, 2026 | Volume: 54 | Issue: 3S | Pages: No page available

10.1097/01.ccm.0001188544.50398.10

777: EFFECT OF STEROIDS ON CYSTATIN C AND ESTIMATED GLOMERULAR FILTRATION RATE IN HOSPITALIZED PATIENTS

Critical Care Medicine | March 24, 2026 | Volume: 54 | Issue: 3S | Pages: No page available

10.1097/01.ccm.0001185104.35935.bf

585: EFFECT OF CYSTATIN C ON INITIAL BIVALIRUDIN DOSE SELECTION IN ACUTELY ILL PATIENTS

Critical Care Medicine | March 24, 2026 | Volume: 54 | Issue: 3S | Pages: No page available

10.1097/01.ccm.0001184336.18728.fe

1460: ACTIVATED FACTOR VII USE FOR REFRACTORY HEMORRHAGE ON ECMO

Critical Care Medicine | March 24, 2026 | Volume: 54 | Issue: 3S | Pages: No page available

10.1097/01.ccm.0001187836.29703.b5